Scorpion venom ion channel-modulating peptides

Scorpion venom ion channel-modulating peptides are a diverse group of low-molecular-mass proteins, typically ranging from 30 to 70 amino acids, that have evolved to target essential physiological components of prey and predators. These peptides exhibit high affinity and extreme specificity for various ion channels, including voltage-gated potassium (K+), calcium-activated potassium (KCa), calcium (Ca2+), and chloride (Cl-) channels (Ortiz et al., 2015). By binding to these channels, they function either as pore blockers that physically obstruct ion flow or as gating modifiers that shift the voltage dependence of channel activation or inactivation (Catterall, 1980). In modern pharmacology, these toxins are utilized as molecular probes and therapeutic leads; for example, the Kv1.3-specific blocker Dalazatide is investigated for treating autoimmune conditions like multiple sclerosis, while chlorotoxin is used for the targeted imaging and treatment of malignant gliomas (Lewis & Garcia, 2003; Deshane et al., 2003). Despite their therapeutic potential, the development of these peptides into clinical drugs is often hindered by challenges such as potential systemic toxicity, rapid renal clearance, and the risk of eliciting an immune response due to their peptide nature.

Other names

Scorpion toxinsKTx (Potassium channel toxins)ClTx (Chloride channel toxins)Calcins (Calcium channel modulators)Short-chain scorpion toxinsNeurotoxins

Pore blockade and gating modification of voltage-gated and ligand-gated ion channels